Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000731480 | SCV000237524 | likely benign | not provided | 2021-04-07 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 23396983, 31983221) |
Labcorp Genetics |
RCV000228035 | SCV000286825 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2015-12-19 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000731480 | SCV000859304 | uncertain significance | not provided | 2018-01-25 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000769949 | SCV000901375 | uncertain significance | Cardiomyopathy | 2017-02-10 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000184806 | SCV000966549 | likely benign | not specified | 2018-08-29 | criteria provided, single submitter | clinical testing | The p.Thr21877Ile variant in TTN is classified as likely benign because it has b een identified in 0.02% (25/125770) of European chromosomes by the Genome Aggreg ation Database (gnomAD, http://gnomad.broadinstitute.org). This variant has also been reported in ClinVar (Variation ID 202848). ACMG/AMP Criteria applied: BS1, PP3. |
Athena Diagnostics | RCV000731480 | SCV001146480 | uncertain significance | not provided | 2019-07-18 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000731480 | SCV002541931 | uncertain significance | not provided | 2021-08-30 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000731480 | SCV003825577 | uncertain significance | not provided | 2020-02-28 | criteria provided, single submitter | clinical testing |